IL-10 is an important anti-inflammatory cytokine that can suppress both innate and adaptive immune responses to infectious agents or auto-antigens[@R1],[@R2]. Certain pathogens exploit IL-10 to suppress the host response and establish chronic infection[@R2]. However, during acute infections that induce strong inflammatory responses, IL-10 often acts beneficially to moderate excessive inflammation[@R2].

While various innate and adaptive immune cell types have been identified as IL-10 producers[@R3], there is increasing evidence that effector T cells are an important source of IL-10 especially during certain parasitic and viral infections[@R4]-[@R6]. Thus, the cells that often produce or enhance inflammation during infection can regulate their pro-inflammatory activity through IL-10 production[@R7]. However, the cellular and molecular mechanisms controlling *in vivo* IL-10 expression in T cells and particularly in effector T cells are imperfectly understood. In certain regulatory T-cells, stiThatmuli such as, dexamethasone plus vitamin D3, IL-27, IL-21, TGF-β and aryl hydrocarbon receptor (AhR) ligands as well as IL-10 itself promote IL-10 production[@R3],[@R8]-[@R12] while IL-27, IL-21 and IL-12 are reported to augment IL-10 production by CD4^+^ effector T cells[@R13]-[@R17]. However, despite the multiple signals identified to promote IL-10 production by T cells, the *in vivo* significance and relative contribution of these signals is poorly defined. Similarly the intracellular signaling intermediates activated by these IL-10 promoting signals in T cells remain under-explored, although STAT3, c-maf and recently AhR have been implicated in controlling IL-10 gene expression in CD4^+^ T cells[@R3],[@R11],[@R12].

Anti-viral CD8^+^ CTL are a major producer of IL-10 in the respiratory tract during influenza infection [@R6]. CTL-derived IL-10 plays a critical role in preventing excess inflammation during immune-mediated virus clearance[@R6]. In this report, we investigate the signals necessary to drive the production of IL-10 by CTL in the infected respiratory tract. Our data reveals a novel interplay between products of T~H~ cells and infiltrating innate immune cells in shaping the function of anti-viral CTL at the site of infection.

Results {#S1}
=======

IL-10^+^ CTL development requires IL-27 and T~H~ cells {#S2}
------------------------------------------------------

To investigate the mechanisms regulating IL-10 production by anti-viral CTL during influenza infection, we first examined whether interferon-γ (IFN-γ) is required since the IL-10-producing CTL co-express IFN-γ ([Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}). IFN-γ is dispensable for the induction of IL-10 producing CTL ([Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}). Similarly, although IL-12 is important to induce IL-10-producing T cells in some settings[@R17], it is not required for the induction of IL-10 producing CTL during influenza infection as CD8^+^ T cells from *p35^−/−^* mice (which lack both IL-12 and IL-35[@R18]) can produce IL-10 ([Fig. 1a](#F1){ref-type="fig"}). IL-27 induces the development of IL-10 producing CD4^+^ T cells[@R3], therefore we examined the role of IL-27 in controlling the induction of IL-10-producing CTL during influenza infection. Influenza infection induces IL-27 gene expression in the respiratory tract ([Supplementary Fig. 2](#SD1){ref-type="supplementary-material"}). We then infected *Ebi3^−/−^* mice (which lack both IL-27 and IL-35[@R18]) with influenza and measured IL-10 production by influenza specific CTL. EBI-3 deficiency does not affect the induction of IFN-γ producing CTL, but substantially impairs the induction of IL-10 producing CTL in both draining lymph nodes (i.e. mediastinal lymph nodes, MLN) and the infected lungs ([Fig. 1b, c](#F1){ref-type="fig"}). Consistent with the impaired production of IL-10 by CTL, *Ebi3^−/−^* mice exhibited impaired IL-10 release in the airway and enhanced pulmonary inflammation during influenza infection ([Supplementary Fig. 3](#SD1){ref-type="supplementary-material"}). The induction of IL-10 producing CD4^+^ T cells by IL-27 is dependent on IL-21 signaling[@R10], however the induction of IL-10 producing CTL during influenza infection is intact in mice lacking IL-21 receptor ([Fig. 1d](#F1){ref-type="fig"}).

The absence of IL-27 did not completely abrogate IL-10 producing CTL, suggesting additional signals contribute to the induction of IL-10 producing CTL. Release of IL-10 *in vivo* is dependent on both CD8^+^ and CD4^+^ T cells[@R6], suggesting a possible role of CD4^+^ T cells in the induction of IL-10 producing CTL. To this end, we have eliminated both IL-27 and CD4^+^ T cells *in vivo* and examined the induction of IL-10 producing CTL following influenza infection. Depletion of CD4^+^ T cells, together with EBI-3 deficiency, almost completely abrogated the induction of IL-10 producing CTL ([Fig. 1e, f](#F1){ref-type="fig"}). Elimination of CD4^+^ T cells and IL-27 also compromised the production of IL-10 at the single cell level ([Fig. 1g](#F1){ref-type="fig"}) in the few remaining IL-10^+^ CTL ([Fig. 1g](#F1){ref-type="fig"}). Taken together, these data suggests that the induction of IL-10 producing CTL during influenza infection is dependent on the presence of both IL-27 and T~H~ cells, but is independent of IL-12, IL-21, IL-35 and IFN-γ.

T~H~ cells selectively induce IL-10^+^ CTL development {#S3}
------------------------------------------------------

The finding that the induction of IL-10 producing CTL *in vivo* requires the presence of CD4^+^ T cells raised the possibility that CD4^+^ T cell "help" is required for the physiologic CTL responses to influenza infection. We therefore examined the role of CD4^+^ T cells in the accumulation and differentiation of CTL in the respiratory tract during influenza infection. The depletion of CD4^+^ T cells severely impairs the production of IL-10, but not IFN-γ nor tumor necrosis factor (TNF) by CTL ([Fig. 2a, b](#F2){ref-type="fig"}). These data agree with reported findings[@R19],[@R20] and suggest that CD4^+^ T cell "help" is minimally required for the differentiation and accumulation of CTL. CD4^+^ T cell depletion at various time points impaired the development of IL-10 producing CTL even at d 6 p.i., i.e. when T cells have entered the infected lungs, suggesting that CD4^+^ T cells are able to help CD8^+^ T cells in the lung as well as in the MLN ([Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}).

To further confirm the impact of CD4^+^ T cell depletion, we infected *MhcII*^−/−^ mice (which lack CD4^+^ T cells) with influenza and found that CD8^+^ T cells from *MhcII*^−/−^ mice were likewise impaired in IL-10 but not IFN-γ or TNF production ([Fig. 2c](#F2){ref-type="fig"}). The absence of CD4^+^ T cells only minimally affected the expression of the cytolytic molecule Granzyme B by CTL ([Supplementary Fig. 5](#SD1){ref-type="supplementary-material"}). We next directly examined the role of CD4^+^ T cell "help" in the *in vivo* induction of IL-10 producing CTL by utilizing IL-10 reporter mice (Vert-X)[@R21]. IL-10 gene expression in CTL is primarily restricted to the site of infection i.e. the lungs ([Supplementary Fig. 6](#SD1){ref-type="supplementary-material"}). Importantly, the depletion of CD4^+^ T cells significantly impaired the development of IL-10-expressing cells among both total lung-infiltrating CD8^+^ T cells as well as gated influenza antigen specific cells ([Fig. 2 d](#F2){ref-type="fig"} and [Supplementary Fig. 6](#SD1){ref-type="supplementary-material"}). We also bred Vert-X mice to *MhcII*^−/−^ mice and infected Vert-X-*MhcII^−/−^* mice with influenza. Compared to the influenza-specific CD8^+^ T cells from littermate Vert-X-*MhcII*^+/−^ mice, influenza-specific T cells from Vert-X-*MhcII*^−/−^ mice had diminished IL-10-expressing cells ([Fig. 2e](#F2){ref-type="fig"}) and IL-10 expression intensity at the single cell level ([Supplementary Fig. 7](#SD1){ref-type="supplementary-material"}). We also verified *in vivo* that CD4^+^ T cell help is not required for the induction of IFN-γ-expressing cells using IFN-γ eYFP reporter mice (Yeti) which were constructed similarly to the Vert-X mice ([Fig. 2 f](#F2){ref-type="fig"} and [Supplementary Fig. 8](#SD1){ref-type="supplementary-material"})[@R22]. Collectively, these data suggest that CD4^+^ T cell "help" is critical for inducing an optimal anti-inflammatory cytokine profile (i.e. IL-10 production) but not for the activation and differentiation of the effector features of influenza specific CTL *in vivo*.

IL-2 provides the "help" for IL-10^+^ CTL development {#S4}
-----------------------------------------------------

To identify the molecule(s) that mediate the "help" from CD4^+^ T cells, we developed an *in vitro* T cell-DC co-culture system. We labeled influenza HA-specific CD8^+^ T cell receptor (TCR) transgenic T cells (CL-4) with CFSE and stimulated them with influenza-infected DC in the absence or presence HA-specific CD4^+^ TCR transgenic T cells (TS-1). CL-4 T cells stimulated with influenza-infected DC expanded and expressed IFN-γ but failed to produce IL-10 ([Fig. 3a](#F3){ref-type="fig"}). However, when CD4^+^ TS-1 cells were included in the culture, CL-4 cells acquired the ability to produce IL-10. Importantly, all IL-10-producing cells were also IFN-γ^+^ ([Supplementary Fig. 9](#SD1){ref-type="supplementary-material"}). These data recapitulate our *in vivo* findings that CD4^+^ T cells are able to provide the "help" to CD8^+^ T cells to induce the development of IL-10 producing CTL.

IL-2 is one of the major cytokine produced by CD4^+^ T cells and has been shown to support expansion and differentiation of CTL[@R23],[@R24]. We therefore evaluated the impact of IL-2 on IL-10 expression by CL-4 T-cells in the co-culture system. Neutralization of murine IL-2 completely blocked the induction of IL-10 producing CL-4 CTL *in vitro* but only modestly affected cell proliferation and IFN-γ production by CTL ([Fig. 3a](#F3){ref-type="fig"}). Importantly, addition of human IL-2 to cultures reversed the effects of mIL-2 neutralization ([Fig. 3a](#F3){ref-type="fig"}). In companion experiments, we purified CD8^+^ T cells from ovalbumin (OVA)-specific TCR transgenic OT-I-Vert-X double transgenic mice (V-OT-I) and cultured the CD8^+^ T cells with DC simultaneously infected with recombinant influenza strains expressing MHC I or MHC II OVA epitopes (influenza-ova) in the presence or absence of OVA-specific CD4^+^ transgenic OT-II T cells. The inclusion of OT-II cells enhanced the development of IL-10-producing V-OT-I CTL which was dependent on IL-2 but independent of IL-6, IL-12 or IL-21 ([Fig. 3b](#F3){ref-type="fig"} and [Supplementary Fig. 10a](#SD1){ref-type="supplementary-material"}). We further established that CD4^+^ T cells are the major IL-2 producing cells in the culture ([Fig. 3c](#F3){ref-type="fig"}). IL-2 is therefore likely the primary molecule derived from CD4^+^ T cells which provides "help" to CD8^+^ T cells to drive the development of IL-10 producing CTL.

Our finding ([Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}) that depletion of CD4^+^ T-cells as late as day 6 p.i. inhibited IL-10 production by CTL in the infected lungs suggested that CD4^+^ T cell-derived IL-2 may not only act at the induction phase of the CD8^+^ T cell response in the draining MLN but also on previously activated CTL in the lungs. To further explore this, we purified V-OT-I and OT-II cells and activated the transgenic CD8^+^ and CD4^+^ T-cells independently in culture for 4 days and then assessed the impact of IL-2 supplementation and/or activated CD4^+^ T cell addition on IL-10 production by the V-OT-I CTL ([Supplementary Fig. 10b](#SD1){ref-type="supplementary-material"}). Antibody-mediated TCR activation of V-OT-I alone modestly upregulated IL-2-independent expression of IL-10 ([Fig. 3d](#F3){ref-type="fig"}, top row). IL-10 expression was further enhanced by the addition of exogenous IL-2 ([Fig. 3d](#F3){ref-type="fig"}, top row). By contrast, co-cultures of previously activated CD8^+^ and CD4^+^ T cells resulted in robust IL-10 expression by CTL following TCR cross-linking ([Fig. 3d](#F3){ref-type="fig"}, bottom row) which is inhibited by IL-2 neutralization ([Fig. 3d](#F3){ref-type="fig"}, bottom row). This finding supports the view that activated CD4^+^ T cells acting via IL- 2 can promote the production of IL-10 by differentiated effector CD8^+^ T cells (CTL). In keeping with this concept, only effector CD4^+^ T cells exhibited robust production of IL-2 ([Fig. 3e](#F3){ref-type="fig"}). When these *in vitro* activated CD8^+^ CTL were treated with IL-2 alone in short-term culture (4h) IL-2 exposure like TCR engagement can stimulate IL-10 expression by CTL but the IL- 2 effect was more potent when signaling in co-operation with TCR engagement ([Fig. 3f](#F3){ref-type="fig"}), suggesting that IL-2 can directly promote the expression of IL-10 independent of its role in promoting CTL proliferation and survival.

IL-2 signaling is required to induce IL-10^+^ CTL *in vivo* {#S5}
-----------------------------------------------------------

We next assessed the contribution of CD4^+^ T cell-derived IL- 2 and IL- 2 signaling to the induction of IL-10 production by anti-viral CTL *in vivo* during influenza infection. We first established *in vivo* that CD4^+^ T cells are the dominant source of IL-2 ([Fig. 4 a, b](#F4){ref-type="fig"} and [Supplementary Fig. 11a](#SD1){ref-type="supplementary-material"}) and the depletion of CD4^+^ T cells abrogates most IL-2 production in both MLN and the lung ([Fig. 4c](#F4){ref-type="fig"}). Furthermore, the absence of CD4^+^ T cells impaired IL-10 but not IL-2 production by CD8^+^ T cells ([Supplementary Fig. 11b](#SD1){ref-type="supplementary-material"}), suggesting that the amount of IL-2 produced by CD8^+^ T cells is not sufficient to drive the maximal production of IL-10 by CTL *in vivo*. In addition, co-transfer of wild-type (WT) CD4^+^ T cells but not *Il2*^−/−^ CD4^+^ T cells with WT CD8^+^ T cells into *Rag2*^−/−^ mice resulted in augmented IL-10 production by CTL (albeit at lower levels than observed with CTL from infected WT mice, likely due to non-specific homeostatic proliferation of transferred CD8^+^ T cells in *Rag2*^−/−^ recipient), suggesting CD4^+^ T cells-derived IL-2 is required for the optimal generation of IL-10 producing CTL *in vivo* ([Supplementary Fig. 12](#SD1){ref-type="supplementary-material"}). In addition, we determined that IL-10-expressing CTL in the infected lungs are IL-2Rα (CD25)^+^, indicating that they are competent for IL-2 signaling ([Supplementary Fig. 13](#SD1){ref-type="supplementary-material"}). To directly establish the requirement for IL-2 receptor signaling, we transferred either WT or *Il2ra*^−/−^ T cells into Thy1 mis-matched congenic mice and then infected the recipient mice with influenza. While transferred WT CD8^+^ T cells or endogenous WT CD8^+^ T cells produced IL-10 in the infected lungs, transfered *Il2ra^−/−^* CD8^+^ T cells failed to produce IL-10 during influenza infection ([Fig. 4d](#F4){ref-type="fig"}). We also made a WT:*Il2ra^−/−^* mixed bone marrow chimera mice and infected these mice with influenza. *Il2ra^−/−^* CTL mounted an antigen-specific IFN-γ response which was moderately diminished compared to WT cells. In contrast, *Il2ra^−/−^* CTL failed to produce IL-10 even when we accounted for the diminished pro-inflammatory cytokine response by normalizing the IL-10 producing cells to antigen specific IFN-γ producing cells ([Fig. 4e, f](#F4){ref-type="fig"}). On the other hand, the *Il2ra^−/−^* CTL are able to produce equivalent level of TNF and only slightly diminished level of Granzyme B compared to WT CTL in the lung ([Fig. 4f](#F4){ref-type="fig"} and [Supplementary Fig. 14](#SD1){ref-type="supplementary-material"}). IL-21 is another important CD4^+^ T cell derived "helper" cytokine. However *Il21r^−/−^* CTL are able to produce IL-10 at levels comparable to WT CTL when influenza infection was carried out in the WT: *Il21r^−/−^* mixed bone marrow chimera mice ([Fig. 4g](#F4){ref-type="fig"}). These data collectively demonstrated that IL-2 (rather than IL-21) is the major CD4^+^ T cell-derived molecule driving the development of IL-10-producing CTL during influenza infection. Furthermore, rIL-2 administration to influenza infected CD4^+^ T cell-depleted mice at the time of effector T cell infiltration into the lung i.e. d5- 6 p.i. enhanced the induction of IL-10 production by CTL ([Fig. 4 h, i](#F4){ref-type="fig"}). Taken together, these data strongly suggest a critical role for IL-2 and IL-2R dependent signaling in stimulating IL-10 production by CTL at the site of virus infection.

IL-2 and IL-27 cooperate to induce IL-10^+^ CTL {#S6}
-----------------------------------------------

Our analysis so far indicates that both CD4^+^ T- cell-derived IL-2 as well as the cytokine IL-27 are necessary for the development of IL-10 producing CTL during influenza infection. Next, we sought to determine if IL-27 and CD4^+^ T cell-derived IL-2 act synergistically to activate IL-10 gene expression by CTL. To this end, we again co-cultured CFSE labeled CL-4 cells with influenza-infected DC in the presence or absence of TS-1 cells. Inclusion of TS-1 cells or IL-27 alone in the culture enhanced the induction of IL-10 producing CTL ([Fig. 5a](#F5){ref-type="fig"}). However, the presence either of TS-1 cells plus IL-27 or IL-2 plus IL-27 together in co-cultured with the CD8^+^ T cells had a synergistic effect on the induction of IL-10 producing CTL ([Fig. 5a](#F5){ref-type="fig"}). Likewise, the synergy between IL-27 and CD4^+^ T cells was dependent primarily on the CD4^+^ T cell-derived IL-2 ([Fig. 5a](#F5){ref-type="fig"}). Although CD4^+^ T cells are the major source of IL-2, CD8^+^ T cells are capable of producing a small amount of IL-2 during activation ([Fig. 3c](#F3){ref-type="fig"}). This small amount of IL-2 produced by CD8^+^ T cells alone was insufficient to drive the development of IL-10 producing CTL. However, in the absence of CD4^+^ T cell derived IL-2, the small amount of CTL derived IL-2 is essential for enhancing the effect of IL-27 on induction of IL-10 producing CTL ([Fig. 5a](#F5){ref-type="fig"}), suggesting that the induction of IL-10 producing CTL by IL-27 likewise requires the presence of IL- 2. The synergy between IL-27 and CD4^+^ T cell -derived IL-2 is also evident at the single cell level ([Fig. 5b](#F5){ref-type="fig"}). Furthermore, IL-27 and IL-2 act synergistically to induce IL-10 producing CTL in the OT-I & OT-II culture system during the initial (primary) activation ([Supplementary Fig. 15](#SD1){ref-type="supplementary-material"}) or at the effector stage ([Supplementary Fig. 16](#SD1){ref-type="supplementary-material"}).

Having established the contribution of CD4^+^ T cells acting via IL-2 to stimulate IL-10 expression by CD8^+^ T cells we wanted to probe the source(s) of the IL-27 *in vivo*. Innate immune cells in the infected lungs are the main source of IL-27 ([Fig. 5c](#F5){ref-type="fig"}). In this regard it is noteworthy that neutrophils may be a major source of IL-27. Interestingly, consistent with the finding that production of IL-10 by CTL is largely restricted to the site of infection, potential IL-27 producing cells including neutrophils and monocytes/macrophages as well as IL-27 mRNA were enriched at the infection site compared to the draining MLN ([Supplementary Fig. 17](#SD1){ref-type="supplementary-material"}). Furthermore, CD4^+^ cell depletion did not affect IL-27 production *in vivo* ([Fig. 5d](#F5){ref-type="fig"}). This confirms that the impaired induction of IL-10 producing CTL in CD4^+^ T cell-depleted mice is not due to the lack of IL-27. IL-27 deficiency also did not impair IL-2 production by T cells ([Supplementary Fig. 18](#SD1){ref-type="supplementary-material"}), suggesting that the impaired induction of IL-10 producing CTL in IL-27-deficient mice is not due to a lack of IL-2 production. Taken together, these data demonstrated that innate cell-derived IL-27 and CD4^+^ T cell derived IL-2 are independently regulated but act in a coordinate manner to induce IL-10 production by CTL in the respiratory tract during influenza infection.

The unexpected finding of cooperation between these two cytokines in the murine system prompted us to investigate whether IL-2 and IL-27 likewise act co-operatively to induce IL-10 production by human CD8^+^ T cells. IL-2 and IL-27 co-operatively induces both IL-10 mRNA expression and IL-10 protein production by CD8^+^ T cells ([Supplementary Fig. 19](#SD1){ref-type="supplementary-material"} and [Fig. 5e](#F5){ref-type="fig"}).

Induction of IL-10 producing CTL require Blimp-1 {#S7}
------------------------------------------------

To begin to define the signaling pathways within CTL controlling the induction of IL-10 gene expression, we investigated transcription factors potentially implicated in controlling IL-10 production by CTL. IL-10^+^ cells expressed higher levels of the transcriptional regulator Blimp-1 than IL-10^−^ CD8^+^ T cells ([Fig. 6a](#F6){ref-type="fig"}). Blimp-1 expression is known to be induced by IL-2 and Blimp-1 deficient CD4^+^ T cells show comparable production of IFN-γ and IL-4 but diminished IL-10 in response to TCR stimulation[@R25],[@R26]. We therefore investigated the role of Blimp-1 in the production of IL-10 by CTL. CD8^+^ T cells from infected lungs of *MhcII*^−/−^ mice express significantly lower levels of Blimp-1 and IL-10 (but not IFN-γ or T-bet) than T cells isolated from littermate control ([Fig. 6b](#F6){ref-type="fig"}). Similarly, T cells from *Ebi3^−/−^* mice display lower levels of Blimp-1 and IL-10 than controls but comparable levels of IFN-γ and c-maf ([Fig. 6c](#F6){ref-type="fig"}). Furthermore, exposure to either IL-2 or IL-27 can enhance Blimp-1 expression in CTL but simultaneous treatment of CTL with both cytokines act synergistically to enhance Blimp-1 expression ([Fig. 6d](#F6){ref-type="fig"}). We then ectopically expressed Blimp-1 in CD8^+^ T cells by transducing CD8^+^ T cells with a Blimp-1 expressing retrovirus. Ectopic expression of Blimp-1 enhanced IL-10 production by CTL ([Fig. 6e](#F6){ref-type="fig"}), although it did not induce IL-10 production by CTL as effectively as IL-2 plus IL-27 (data not shown), suggesting additional factors may contribute to maximal IL-10 production by CTL. We next wished to determine if IL-2 or IL-27 induced IL-10 production by CTL requires Blimp-1 expression by CTL. To this end, we isolated CD8^+^ T cells from WT mice or mice with *Prdm1* (the gene encoding Blimp-1) selectively disrupted in T cells (CD4-Cre-*Prdm1*^fl/fl^) and stimulated them with DC plus soluble anti-CD3 in the absence or presence of IL-27, IL-2 or the combination of the two cytokines. CD8^+^ T cells lacking Blimp-1 proliferated normally but failed to produce IL-10 in response to IL-2, IL-27 or IL-2 plus IL-27 ([Fig. 6f](#F6){ref-type="fig"}). Thus, IL-2-IL-27 mediated induction of IL-10 production by CTL *in vitro* is Blimp-1 dependent.

The in vivo induction of IL-10^+^ CTL requires Blimp-1 {#S8}
------------------------------------------------------

We next evaluated whether Blimp-1 is required for IL-10 production by CTL *in vivo*. To evaluate this, we infected CD4-Cre *Prdm1*^fl/fl^ (cKO) mice with influenza and at day 7 p.i. measured IL-10 production by CTL in the MLN and infected lungs. Compared to CD8^+^ T cells from influenza infected control Blimp-1 sufficient (CD4-Cre *Prdm1*^fl/+^) mice, Blimp-1 deficient CD8^+^ T cells exhibited markedly diminished IL-10 production ([Fig. 7a, b](#F7){ref-type="fig"}) with comparable production of IFN-γ or TNF following influenza infection ([Fig. 7a, b](#F7){ref-type="fig"}). The selective deficit in IL-10 production was also evident in the bronchioalveolar lavage fluid (BALF) of the infected *Prdm1* cKO mice ([Fig. 7c](#F7){ref-type="fig"}). The diminished release of IL-10 into the BALF likely also reflects defective IL-10 production by CD4^+^ T cells since the production of IL-10 by CD4^+^ T cells is also impaired in *Prdm1* cKO mice (data not shown). *Prdm1* cKO mice also demonstrated enhanced pulmonary inflammation in response to infection characterized by increased infiltration of the infected lungs by mononuclear and granulocytic inflammatory cells and enhanced production of proinflammatory cytokines similar to the impact of IL-10R blockade ([Fig. 7d](#F7){ref-type="fig"} and [Supplementary Fig. 20](#SD1){ref-type="supplementary-material"})[@R6]. Next we sought to address whether the impaired IL-10 production by CD8^+^ T cells from *Prdm1* cKO mice is a CD8^+^ T cell intrinsic defect. We first observed that infected *Prdm1* cKO mice exhibited comparable levels of IL-27 in the respiratory tract as infected WT mice along with moderately diminished IL-2 production due to the diminished production of IL-2 by CD4^+^ T cells but increased production of IL-2 by CD8^+^ T cells respectively ([Supplementary Fig. 21](#SD1){ref-type="supplementary-material"} and data not shown). To directly examine the role of Blimp-1 expression in regulating IL-10 production by CTL, we transferred WT or Blimp-1 deficient T cells into Thy1 mismatched mice and analyzed IFN-γ, TNF and IL-10 production by CTL following influenza infection. Transferred Blimp-1 deficient but not WT CTL failed to produce IL-10 in response to antigenic stimulation ([Fig. 7e](#F7){ref-type="fig"} and [Supplementary Fig. 22](#SD1){ref-type="supplementary-material"}). Together these data suggest that the role of Blimp-1 in regulating IL-10 production by CTL is cell-intrinsic.

Discussion {#S9}
==========

CD4^+^ T-cell "help" for CD8^+^ T cell responses have been previously demonstrated to be required for memory CTL formation, maintenance and recall responses[@R27]-[@R29], in CTL migration to mucosal surfaces[@R30] and in certain experimental settings for optimum primary CTL responses to weak stimuli[@R31]-[@R33]. Strong inflammatory stimuli like influenza infection, however, trigger potent primary CTL responses independent of CD4^+^ T cell "help"[@R19],[@R20]. Our results support this concept as CD4^+^ T cell "help" is minimally required for expression of type 1 effector cytokines such as IFN-γ and cytolytic machinery such as Granzyme B by CTL *in vivo*. However, without CD4^+^ T cell "help", anti-virus CTL activation and differentiation is incomplete since CTL are unable to optimally produce IL-10, a critical regulatory cytokine necessary to control excess lung inflammation during immune mediated virus clearance[@R6].

IL-2 has been shown to promote CTL memory and to support terminal effector cell differentiation by up regulating cytolytic molecules e.g. Granzyme B in secondary lymphoid organs[@R23],[@R34],[@R35]. Our findings on the impact of defective IL-2 signaling on Granzyme B expression by proliferating and/or differentiating CTL in the draining MLN support these earlier findings[@R23],[@R34],[@R35]. However, within the inflammatory milieu of the infected lungs, other signals can replace IL- 2 in the induction of CTL Granzyme B. Proinflammatory molecules such as type I interferons which can induce antigen-independent Granzyme B expression in CTL within the respiratory tract[@R36], may replace IL-2. By contrast we find that IL-2 has a critical non-redundant role in promoting the induction of IL-10 producing CTL.

Here we also demonstrated a synergistic role for IL-27 in the CD4^+^ T cell mediated induction of IL-10 by CTL. Although recognized as a stimulator of T~H~1 responses, IL-27 has more recently been appreciated as an important IL-10 independent and dependent regulator of host immune responses[@R37] e.g. induction of IL-10 expression by CD4^+^ Tr1 and CD4^+^ effector cells *in vivo*[@R10],[@R14],[@R15]. Our findings suggest that anti-viral CTL within the virally-infected lungs are also targets of IL-27 *in vivo*. While IL-27 is generally believed to be the product of activated macrophages and DC[@R38], our results suggest that neutrophils may also be an important source of IL-27 during acute respiratory viral infections. This interplay between inflammatory myeloid cell-derived IL-27 and CTL-derived IL-10 suggests a novel regulatory loop where influx of inflammatory myeloid cells into the infected lungs in response to infection augments IL-10 production by CTL responding to infection which in turn dampens both the activation state of the innate immune cells and additional infiltration of these myeloid inflammatory cells[@R6].

Blimp-1 is a transcriptional repressor that plays a role in B cell differentiation, as well as T cell homeostasis, T effector cell differentiation and migration[@R39]. As previously reported [@R40], Blimp-1deficient CTL demonstrated a modest deficit in migration into the influenza infected lungs but the Blimp-1 deficient CTL within the infected lungs exhibit no deficit in pro-inflammatory effector cytokine production. Blimp-1 deficient CTL were, however, drastically impaired in IL-10 production, suggesting stringent requirements for Blimp-1 expression by IL-10 producing CTL *in vivo* in the infected lungs. Consistent with this hypothesis, IL-2- and/or IL-27- dependent IL-10 production by CTL *in vitro* required their expression of Blimp-1. Of note both IL-10 non-producing (IL-10^−^) and IL-10^+^ CTL express Blimp-1 but the IL-10^+^ CTL express 2-3 fold higher levels of Blimp-1. Thus a modest difference in the level of expression of this transcriptional regulator appears to markedly influence the ability of the activated CTL to express the IL-10 gene, a result consistent with recently published evidence relating Blimp-1 gene dosage to CD8^+^ T cell exhaustion[@R41]. While our findings indicate a likely non-redundant requirement for both Blimp-1 and IL-2 to generate IL-10 producing CTL, both IL-10^+^ and IL-10^−^CTL express Blimp-1 and are exposed to IL-2 and IL-27 in the infected lungs. Undoubtedly other, as yet unidentified factors, also play a part in controlling IL-10 gene expression by CTL in the infected respiratory tract.

In summary, we have described the cellular and molecular mechanisms controlling a regulatory cytokine production by anti-viral CTL. Our data reveals a novel co-ordination between innate cell-derived signal and T~H~ cell-derived signal in fine-tuning the anti-viral CTL responses during acute respiratory virus infection. Our findings may provide the groundwork for future studies in manipulating IL-10 production in anti-viral T cells to control excessive host inflammation during acute respiratory virus infection.

Online Methods {#S10}
==============

Mouse and infection {#S11}
-------------------

C57/BL6, BALB/c, *Rag2*^−/−^*, Ebi3*^−/−^, *Ifng*^−/−^, *p35*^−/−^, OT-II, *Prdm1*^fl/fl^, *MhcII*^−/−^, CD4-Cre transgenic mice were purchased from Taconic Farm or The Jackson Laboratories. Vert-X mice [@R21] were from Dr. Christopher Karp at Cincinnati Children Hospital Medical Center, *Il21r*^−/−^ mice were from Dr. Warren Leonard at NIH, Yeti mice [@R22] were from Dr. Markus Mohrs at Trudeau Institute. CL-4, TS-1, *Il2ra*^−/−^, *Il2*^−/−^, *MhcII*^−/−^-Vert-x and Vert-X-OT-I mice were bred in house. All mice were housed in a specific pathogen-free environment and all animal experiments were performed in accordance with protocols approved by the University of Virginia Animal Care and Use Committee. For virus infection, mice were infected with sub-lethal dose of A/PR/8-34 in serum free Iscove\'s media intranasally following anesthesia with ketamine and xylazine.

Quantitative RT-PCR {#S12}
-------------------

Lung cell suspensions were prepared as described[@R42]. CD8^+^ cells were purified through MACS-beads (Miltenyi Biotech). mRNA isolation, reverse transcription and realtime PCR were performed as previously described[@R6]. Data were generated with the Delta CT method by normalizing to hypoxanthine phosphoribosyltransferase (HPRT).

Influenza-specific CD8^+^ T cell restimulation by BMDC {#S13}
------------------------------------------------------

BMDC were harvested on day 6-7 post culture with GM-CSF and infected with influenza at approximated 100 M.O.I. overnight. Then BMDC were counted and mixed with lung or MLN cells at a 1.5 to 1 ratio in the presence of Golgi-Stop (BD Biosciences) and hIL-2 (40U/ml) for additional 6-7 h. The surface staining of cell surface markers, intracellular staining of cytokines were performed as described[@R6].

DC/T cell co-culture {#S14}
--------------------

CD4^+^ and CD8^+^ transgenic T cells were isolated from spleen and lymph nodes of indicated mice through MACS-beads (Miltenyi Biotech). Splenic DC were isolated from spleen of WT mice through MACS-beads (Miltenyi Biotech). Then DC were infected with approximately with 100 M.O.I. of virus (For CL-4/TS-1 experiments, DC were infected with influenza A/PR8; for OT-I/OT-II experiments, DC were infected with recombinant influenza A/PR8-OT-I plus A/PR8-OT-II virus). Then, DC were mixed with CFSE labeled CD8^+^ T cells (5×10^4^) at the ratio of 1 DC : 10 T cells in round-bottom 96 wells. In some wells, we included the same number of CD4^+^ T cells. The conditions of the culture are indicated in the text. For experiments cultured with WT or Blimp-1 deficient CD8^+^ T cells. We stimulated T cells with soluble α-CD3 (0.05 μg/ml) with influenza infected BMDC at the ratio of 1 DC : 10 T cells. The T cells were cultured for 4 d and restimulated with either cognate peptide (1 μg/ml) or PMA (100ng/ml) plus ionomycin (1 μg/ml) in the presence of Golgi-Stop (1 μl/ml). For the secondary culture with activated effector T cells. V-OT-I or OT-II cells were activated separately as described above. Then 5×10^4^ V-OT-I cells or V-OT-I (5×10^4^) plus OT-II cells (5×10^4^) were left unstimulated or stimulated with plate-bound α-CD3 (coated with 50μl 1μg/ml in PBS for 3-4h in 37 °C) for 2d. All blocking Abs are used at the concentration of 20 μg/ml. recombinant human IL-2 and mouse IL-27 were used as 300 U/ml and 10 ng/ml respectively.

Human CD8^+^ T cell culture {#S15}
---------------------------

CD8^+^ T cells were isolated from periphery blood of healthy individuals via MACS. 5×10^4^ CD8^+^ T cells were then stimulated with plate bound α-CD3 plus α-CD28 (50μl 4μg/ml in PBS for 3-4h in 37 °C) for 3d in the presence or absence of hIL-2 (300 U/ml) and/or rhIL-27 (10 ng/ml). Then the culture supernatant were harvested for human IL-10 ELISA and cells were harvested for quantitative RT-PCR analysis for IL-10 expression.

Bone marrow Chimera {#S16}
-------------------

To generate WT and *Il2ra*^−/−^ mixed bone marrow chimera, we lethally irradiated (1020 Rads) WT mice and reconstituted the irradiated mice with Thy1.1^+^ WT bone marrow mixed with Thy1.2^+^*Il2ra*^−/−^ bone marrow. To generate WT and *Il21r*^−/−^ mixed bone marrow chimera, we lethally irradiated (1020 Rads) WT mice and reconstituted the irradiated mice with CD45.1^+^ WT bone marrow mixed with CD45.2^+^*Il21r*^−/−^ bone marrow. After 8-10 weeks, the reconstituted mice were then infected influenza.

Cell transfer and infection {#S17}
---------------------------

For T cells transferring into WT mice: cells were isolated from Thy1.2^+^ WT, *Il2ra*^−/−^ or CD4-Cre *Prdm1*^fl/fl^ spleen and lymph nodes. A total of 50 million cells were then transferred into Thy1.1^+^ mice. 24h later, the recipient mice were infected with influenza. For CD4^+^ and CD8^+^ T cell transferring into *Rag2*^−/−^ mice: 15 million purified WT CD8^+^ T cells were either alone or mixed with 30 million purified WT CD4^+^ T cells or *Il2*^−/−^ CD4^+^ T cells and then transferred into *Rag2*^−/−^ mice. 24h later, recipient mice were infected with influenza. At d9 p.i., lung cells were collected and IL-10/IFN-γ production by CD8^+^ T cells were determined.

Cell sorting {#S18}
------------

For experiments to measure IL-27 expression, WT mice were infected with influenza and at different cell populations were sorted based on following markers at d5 p.i.: Neutrophils: CD11b^+^Ly6G^+^; DCs, MHCII^hi^CD11c^hi^; Monocytes/macrophages, CD11b^+^MHCII^+^CD11c^−\ or\ low^; T cells, Thy1.2^+^, lung resident cells, CD45^−^. For effector T cells sorting from infected Vert-X mice, we sorted CD44^hi^IL-10-eGFP^+^ or CD44^hi^IL-10-eGFP^−^ CD8^+^ T cells from d7 infected lungs.

Retroviral transduction {#S19}
-----------------------

Control pMI retroviral vector and Blimp-1 containing pMI retroviral vector were a gift from Dr. Thomas R. Malek at the University of Miami [@R25]. Retroviral supernatants were generated by transient transfection of HEK-293T cells with *Trans*IT-LT1 reagent (Mirus) in the presence of pCL-Eco Retrovirus packaging plasmid. Retrovirus-containing supernatants were collected 48 h after transfection and used for spin infection (2,500 rpm, 2 h) of pre-activated OT-I cells (BMDC plus 1 μg/ml of OVA peptide for 24h). Then cells were washed and placed into culture with influenza-OVA infected DC for additional 3d.

Flow cytometry analysis {#S20}
-----------------------

Antibodies were purchased from BD Biosciences or eBioscience. Cells were acquired through a 6-color FACS-Canto system (BD Biosciences). Data were then analyzed by FlowJo software (Treestar).

Statistical analysis {#S21}
--------------------

Data are mean ± s.e.m. Two-tailed Student\'s t-test was used. \*, *P* values \<= 0.05. \*\*, *P* values \<= 0.01.
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![Induction of IL-10 producing CTL *in vivo* requires IL-27 and CD4^+^ T cells\
(a) WT or *p35*^−/−^ mice were infected with influenza. At d7 p.i., the production of IL-10 and IFN-γ by CTL from MLN or lungs was measured by ICS. (b, c) WT or *Ebi3*^−/−^ mice were infected with influenza. At d7 p.i., the production of IL-10 and IFN-γ by CTL from MLN or lungs was measured by ICS. (c) The normalized percentages of IL-10^+^ cells in influenza-specific CTL (IFN-γ^+^) from MLN or lungs of infected WT and *Ebi3*^−/−^ mice are depicted. (d) WT or *Il21r*^−/−^ mice were infected with influenza. At d7 p.i., the production of IL-10 and IFN-γ by CTL from MLN or lungs was measured by ICS. (e, f, g) WT, *Ebi3*^−/−^ or CD4^+^ T cell-depleted (α-CD4) *Ebi3*^−/−^ mice were infected with influenza. At d7 p.i., the production of IL-10 and IFN-γ by CTL from MLN or lungs was measured by ICS. (f) The normalized percentages of IL-10^+^ cells in influenza-specific CTL (IFN-γ^+^) from MLN or lungs of WT and *Ebi3*^−/−^ mice are depicted. (g) The mean fluorescence intensity (MFI) of IL-10 in IL-10^+^ cells from infected lungs is depicted. Numbers are the percentages of cells in gated population. \*, *P* \<= 0.05; \*\*, *P* \<= 0.01. Data are from one experiment, but are typical of those obtained from at least two.](nihms-263882-f0001){#F1}

![CD4^+^ T cell "help" is selectively required for the induction of IL-10 producing CTL *in vivo*\
(a, b) WT mice were injected with Rat IgG or anti-CD4 (α-CD4) depleting Ab and infected with influenza. At d8 p.i., the production of IL-10, IFN-γ and TNF by CTL from MLN or lungs was measured by ICS. (b) The normalized percentages of IL-10^+^ or TNF^+^ cells in influenza-specific CTL (IFN-γ^+^) from MLN or lungs are depicted. (c) WT or *MhcII*^−/−^ mice were infected with influenza. At d7 p.i., the normalized percentages of IL-10^+^ or TNF^+^ cells in influenza-specific CTL (IFN-γ^+^) from lungs of WT and *MhcII*^−/−^ are depicted. (d) Vert-X mice were injected with Rat IgG or anti-CD4 Ab and infected with influenza. At d7 p.i., the percentages of IL-10-eGFP^+^ cells in influenza-specific PA~224~ or NP~366~ tetramer^+^ cells are depicted. (e) *MhcII*^+/−^-Vert-X or *MhcII*^−/−^-Vert-X mice were infected with influenza. At d7 p.i., the percentages of IL-10-eGFP^+^ cells in influenza-specific lung PA~224~ or NP~366~ tetramer^+^ cells are depicted. (f) Yeti mice were injected with Rat IgG or α-CD4 Ab and infected with influenza. At d7 p.i., the percentages of IFN-γ-eYFP^+^ cells in influenza-specific lung PA~224~ or NP~366~ tetramer^+^ cells are depicted. Numbers are the percentages of cells in gated population. \*, *P* \<= 0.05; \*\*, *P* \<= 0.01. (a-d, f) Data are from one experiment, but are typical of three. (e) Data are pooled from total of four experiments.](nihms-263882-f0002){#F2}

![IL-2 provides the "help" from CD4^+^ T cell to CTL for IL-10 production *in vitro*\
(a) CFSE labeled CD8^+^ CL-4 cells were stimulated with influenza-infected DC in the presence or absence of CD4^+^ TS-1 cells for 4d. The cultured cells were treated with indicated conditions. Then the production of IL-10 and IFN-γ by CL-4 cells were measured through ICS. (b, c) CD8^+^ Vert-X-OT-I (V-OT-I) cells were stimulated with influenza-OVA-infected DC in the absence or presence of OT-II cells. (b) The percentages of IL-10-eGFP^+^ cells in V-OT-I cells are depicted. (c) The release of IL-2 into medium after 2d in culture was measured by ELISA. (d, e) V-OT-I or OT-II cells were activated separately by influenza-OVA-infected DC for 4d. The activated V-OT-I cells were unmanipulated or co-cultured with the activated OT-II cells. Cells were then either left unstimulated or stimulated with plate-bound anti-CD3 (α-CD3). The cultured cells were treated as indicated. (d) The expression of IL-10-eGFP by V-OT-I cells after 2d in culture was measured by flow cytometry. (e) The release of IL-2 into medium after overnight in culture was measured by ELISA. (f) OT-I cells were stimulated with influenza-OVA-infected DC. After 4 d in culture, OT-I cells were treated with hIL-2 or hIL-2 plus plate-bound α-CD3 for 4h. The expression of IL-10 was measured by quantitative RT-PCR. Numbers are the percentages of cells in the gated population. Data are from one experiment, but are representatives of at least 3 replicates.](nihms-263882-f0003){#F3}

![IL-2 is required for the induction IL-10-producing CTL *in vivo*\
(a, b). IL-2 production by gated Thy1^+^ cells from influenza infected lung is measured by ICS. (a) IL-2 production by Thy1^+^CD4^+^ and Thy1^+^CD4^−^ cells depicted (b) with the indicated IL-2 MFI (c) IL-2 production by cultured MLN and lung cells from influenza infected mice treated with indicated antibodies is determined by ELISA. (d) Following transfer of WT or *Il2ra*^−/−^ T cells into Thy1.1 mice and influenza infection, the normalized percentages of IL-10^+^ cells among influenza-specific CTL (IFN-γ^+^) from infected lungs at d8 p.i. is determined. (e, f) WT:*Il2ra*^−/−^ chimeric mice were infected with influenza. At d7 p.i., the production of IL-10, TNF and IFN-γ by CTL was measured by ICS. (f) The normalized percentages of IL-10^+^ or TNF^+^ cells among lung influenza-specific CTL (IFN-γ^+^) are depicted. (g) Following infection of WT:*Il2ra*^−/−^ chimeric mice the normalized percentages of lung IL-10^+^ cells among specific IFN-γ^+^ CD8^+^ T cells at d7 p.i., are depicted. (h, i) Following α-CD4 Ab treatment and influenza infection Vert-X mice received rmIL-2 or PBS at d5 and 6 p.i.,. The expression of IL-10-eGFP by CTL was measured by flow cytometry. (i) At d7 p.i, the percentages of IL-10-eGFP^+^ cells among gated CTL are depicted. Numbers represent percentages of cells in gated population. \*, *P* \<= 0.05; \*\*, *P* \<= 0.01. Data are representative of at least two experiments.](nihms-263882-f0004){#F4}

![IL-2 and IL-27 synergistically induce IL-10 production by both murine and human CTL\
(a, b) CFSE labeled CD8^+^ CL-4 cells were stimulated with influenza-infected DC in the presence or absence of CD4^+^ TS-1 cells for 4d. The cultured cells were treated with indicated conditions. Then the production of IL-10 and IFN-γ by CL-4 cells were measured through ICS. (b) The MFI of IL-10 in IL-10^+^ cells is depicted. (c) WT mice were infected with influenza and various cell types of the infected lungs were sorted out as described in methods. The expression of IL-27 EBI-3 and p28 subunits was measured through quantitative RT-PCR. (d) WT mice were injected with Rat IgG or α-CD4 Ab and infected with influenza. At d6 p.i., the levels of IL-27 p28 in BALF were measured through ELISA. (e) Purified human CD8^+^ T cells were stimulated with α-CD3 plus α-CD28 with indicated conditions for 3d. Then the levels of IL-10 in the medium were measured by ELISA. Numbers are the percentages of cells in gated population. (a-d) Data are representative of at least three separate experiments. (e) Data are representative of at least two separate experiments employing an additional donor.](nihms-263882-f0005){#F5}

![Induction of IL-10 producing CTL by IL-2 and IL-27 is Blimp-1 dependent\
(a) Vert-X mice were infected with influenza. At d7 p.i., lung CD8^+^ CD44^hi^IL-10-eGFP^−^ cells and CD8^+^ CD44^hi^IL-10-eGFP^+^ cells were FACS sorted. The expression of IL-10 and Blimp-1 were measured by quantitative RT-PCR. (b) *MhcII*^+/−^ or *MhcII*^−/−^ mice were infected with influenza. At d7 p.i., lung CD8^+^ cells were isolated and the expression of IL-10, Blimp-1, IFN-γ and T-bet was determined by quantitative RT-PCR. (c) WT or *Ebi3*^−/−^ mice were infected with influenza. At d7 p.i., lung CD8^+^ cells were isolated and the expression of IL-10, Blimp-1, IFN-γ and T-bet was determined by quantitative RT-PCR. (d) OT-I cells were cultured with influenza-OVA infected DC in the absence or presence of hIL-2, IL-27 or hIL-2 plus IL-27 for 4d. The expression of Blimp-1 was measured by quantitative RT-PCR. (e) OT-I cells were transduced with control vector (mock) or Blimp-1 expressing retrovirus (Blimp-1). Then cells were cultured for additional 3 days and IL-10 production by OT-I cells measured by ICS. hCD2^−^ (untransduced cells), hCD2^+^ (transduced cells). (f) CFSE labeled CD8^+^ T cells from WT or CD4-Cre *Prdm*^fl/fl^ (*Prdm1* cKO) mice were stimulated with DC plus soluble α-CD3 for 4 days under indicated conditions and IL-10 production by CTL then measured by ICS. Numbers are the percentages of cells in the gated population. Data are representative of at least two independent experiments.](nihms-263882-f0006){#F6}

![Blimp-1 deficiency in T cells results in diminished IL-10 production and enhanced pulmonary inflammation\
CD4-Cre *Prdm1*^fl/+^ or CD4-Cre *Prdm1*^fl/fl^ mice were infected with influenza. (a, b) At d7 p.i., the production of IL-10 and IFN-γ by CTL was measured by ICS. (b) The normalized percentages of IL-10^+^ or TNF^+^ cells in influenza-specific CTL (IFN-γ^+^) in CD4-Cre *Prdm1*^fl/+^ or CD4-Cre *Prdm1*^fl/fl^ mice are depicted. (c) At d7 p.i., the levels of IL-10 and IFN-γ in BALF were determined through ELISA. (d) At d9 p.i., the numbers of lung monocytes and neutrophils were measured through flow cytometry. Numbers are the percentages of cells in gated population. \*, *P* \<= 0.05; \*\*, *P* \<= 0.01. (b, c) Data are from three pooled experiments. (e) WT or CD4-Cre *Prdm1*^fl/fl^ T cells were transferred into Thy1.1^+^ WT mice and infected with influenza. At d7 p.i., the production of IL-10 and IFN-γ by CTL was measured by ICS following restimulation with influenza-infected BMDC. The normalized percentages of IL-10^+^ cells in influenza-specific CTL (IFN-γ^+^) from infected lungs are depicted. Pooled data from two experiments are represented.](nihms-263882-f0007){#F7}
